Safar Partners

Finwave Semiconductor specializes in the development of advanced gallium nitride (GaN) transistors and integrated circuits (ICs) tailored for 5G communications and power conversion applications. The company utilizes a unique 3DGaN technology, specifically its differentiated fin field-effect transistor (FinFET) design, to enhance the performance of high-volume applications such as radio frequency front end (RFFE) systems for mobile devices. This innovative approach allows Finwave to create semiconductor materials with distinct properties, contributing to advancements in electronics and energy management.

Quaise is an energy company pioneering millimeter wave drilling technology to access deep geothermal energy. Quaise is developing and commercializing novel millimeter wave drilling systems to harness geothermal energy around the globe, overcoming the geographic constraints limiting this energy source today.

Foundation Alloy leverage advanced materials technology to design novel alloys optimized for additive manufacturing.

Seaspire Skincare specializes in the development and manufacturing of multifunctional colorants and active ingredients derived from oceanic biodiversity. The company focuses on creating innovative solutions to address chronic and cosmetic hair and skin conditions while aiming to replace harmful components in traditional sunscreens. One of its key products features the biomolecule Xanthochrome, which provides enhanced protection against a wider spectrum of ultraviolet radiation compared to existing physical and chemical filters. This technology is designed for preventative skincare, promoting a healthier approach that minimizes adverse effects on both human and marine health. Through its sustainable and less toxic formulations, Seaspire Skincare contributes to advancing the skincare industry towards safer and environmentally friendly practices.

Concerto Biosciences discovers and develops specific combinations of microbial ensembles. Using kChip, a patented, high-throughput platform that constructs and screens millions of defined microbial communities - Concerto creates massive data sets on how microbes function when growing in complex communities. From these data, Concerto directly discovers microbial ensembles that perform a desired task and learns design rules for ensemble engineering.

Developer of a light-activated biomaterial platform designed to bring innovation in ocular and regenerative therapies. The company's platform focuses on bio-adhesion, tissue regeneration, tunable mechanics, and therapeutic loading across modalities from small molecules to cell and gene therapies through its photo crosslinked hydrogels, providing medical professionals to perform cell-based therapies for vision restoration, intraocular sustained release of small molecules and peptides, and in situ forming bioadhesives.

RightHand Robotics, Inc. specializes in manufacturing robotic order-picking systems designed for various industrial applications, including e-commerce, food handling, and flexible manufacturing. The company offers innovative products such as the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that enhances the robots' ability to grasp items gently and make adjustments to avoid errors. Their technology allows robots to automatically grasp a wide range of items from bins and cases, eliminating the need for extensive data-entry or parameter-tuning, thereby making the systems cost-effective and adaptable to the evolving needs of businesses. Founded in 2015, RightHand Robotics is headquartered in Cambridge, Massachusetts, with a sales and business development office located in Frankfurt, Germany.

Boston Meats, Inc. produces alternative meat products using proteins. It also develops fiber production technology to produce meats using natural proteins. The company was founded in 2020 and is based in Somerville, Massachusetts.

Quaise is an energy company pioneering millimeter wave drilling technology to access deep geothermal energy. Quaise is developing and commercializing novel millimeter wave drilling systems to harness geothermal energy around the globe, overcoming the geographic constraints limiting this energy source today.

Via Separations, Inc. is a company based in Somerville, Massachusetts, focused on developing membrane-based products for the efficient separation of industrial liquids in complex environments. Incorporated in 2016, the company utilizes advanced materials technology that significantly reduces energy consumption—reportedly using ten times less energy than traditional separation methods. Via Separations specializes in industrial decarbonization through its innovative membrane filtration systems, improving selectivity between nano filtration solutes while enhancing temperature stability, solvent resistance, and oxidizer tolerance. This enables manufacturing facilities to increase productivity while minimizing their energy usage.

Verve Motion specializes in the development of lightweight wearable exo-suits aimed at enhancing the safety and comfort of workers engaged in physically demanding tasks. By integrating robotics, apparel design, and movement science, the company creates innovative textile-based solutions that adapt to the movements of the wearer. These exo-suits provide support by delivering force at critical moments while remaining nonrestrictive, thereby promoting a safer work environment. Additionally, Verve Motion's designs contribute to a more restful experience for workers during their off-hours.

Concerto Biosciences discovers and develops specific combinations of microbial ensembles. Using kChip, a patented, high-throughput platform that constructs and screens millions of defined microbial communities - Concerto creates massive data sets on how microbes function when growing in complex communities. From these data, Concerto directly discovers microbial ensembles that perform a desired task and learns design rules for ensemble engineering.

Boston Meats, Inc. produces alternative meat products using proteins. It also develops fiber production technology to produce meats using natural proteins. The company was founded in 2020 and is based in Somerville, Massachusetts.

Humanyze is a company that specializes in workplace solutions, focusing on improving organizational performance through people analytics. Founded in 2010 and headquartered in Boston, Massachusetts, with operations in Amsterdam, the Netherlands, Humanyze offers a platform called Wyze. This platform enables deployment administrators to configure essential company information, provides users with insightful dashboards, and facilitates benchmarking against external data sources. Additionally, Humanyze integrates with internal systems to generate insights across various teams, job roles, divisions, and departments. The company also utilizes wearable sensors and digital data to enhance its analytics capabilities. Humanyze's unique approach combines technology developed at the MIT Media Lab with small Bluetooth beacons, allowing users to gather and analyze data either for individual use or in an anonymized and aggregated manner for management purposes.

Boston Meats, Inc. produces alternative meat products using proteins. It also develops fiber production technology to produce meats using natural proteins. The company was founded in 2020 and is based in Somerville, Massachusetts.

Radical Plastics, Inc., based in Winchester, Massachusetts, develops biodegradable plastic compounds designed to address plastic pollution. Incorporated in 2018, the company utilizes a proprietary, naturally occurring catalyst to blend with conventional plastics, making them fully biodegradable in the natural environment. Their innovative technology offers soil degradable compounds specifically for agricultural film, providing an economically viable solution for brands seeking drop-in replacements for traditional plastics. Through its commitment to sustainability, Radical Plastics aims to contribute to reducing plastic waste and promoting environmental health.

Cogito Corporation is a Boston-based company that specializes in behavioral analytics software utilizing artificial intelligence technology to enhance human interactions. Its primary offering is a suite of solutions designed to analyze voice conversations in real time, providing professionals in sales, service, and care management with insights into emotional intelligence. This enables them to improve sales outcomes, customer experiences, and quality of care. Key products include Cogito Dialog, which delivers in-call analysis of customer interactions; Cogito Central, which continuously scores customer engagements for signs of distress; and Cogito Companion, a mobile application that alerts healthcare providers to behavioral changes indicating potential mental health risks. By leveraging validated behavioral science through AI and machine learning, Cogito's solutions aim to boost productivity and improve service delivery, fostering better relationships between professionals and their customers. The company, originally known as Cogito Health Inc., was founded in 2007.

RightHand Robotics, Inc. specializes in manufacturing robotic order-picking systems designed for various industrial applications, including e-commerce, food handling, and flexible manufacturing. The company offers innovative products such as the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that enhances the robots' ability to grasp items gently and make adjustments to avoid errors. Their technology allows robots to automatically grasp a wide range of items from bins and cases, eliminating the need for extensive data-entry or parameter-tuning, thereby making the systems cost-effective and adaptable to the evolving needs of businesses. Founded in 2015, RightHand Robotics is headquartered in Cambridge, Massachusetts, with a sales and business development office located in Frankfurt, Germany.

Quaise is an energy company pioneering millimeter wave drilling technology to access deep geothermal energy. Quaise is developing and commercializing novel millimeter wave drilling systems to harness geothermal energy around the globe, overcoming the geographic constraints limiting this energy source today.

Developer of a light-activated biomaterial platform designed to bring innovation in ocular and regenerative therapies. The company's platform focuses on bio-adhesion, tissue regeneration, tunable mechanics, and therapeutic loading across modalities from small molecules to cell and gene therapies through its photo crosslinked hydrogels, providing medical professionals to perform cell-based therapies for vision restoration, intraocular sustained release of small molecules and peptides, and in situ forming bioadhesives.

Commonwealth Fusion Systems LLC is a research company focused on developing fusion energy as a sustainable solution to combat climate change. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes advanced rare-earth barium copper oxide superconductor technology to create energy through fusion. Commonwealth Fusion Systems combines decades of government-funded fusion research with innovative superconducting magnet technology to expedite the commercialization of fusion energy. The company emerged from the Massachusetts Institute of Technology and collaborates closely with MIT’s Plasma Science and Fusion Center, leveraging extensive research to enhance its development efforts. By designing and building fusion machines, Commonwealth Fusion aims to provide limitless and clean energy, contributing to the global transition toward sustainable energy sources.

Kebotix, Inc. is a company focused on revolutionizing the materials discovery and production process through the integration of artificial intelligence, machine learning, and robotics. Founded in 2017 and headquartered in Cambridge, Massachusetts, Kebotix has developed a platform that significantly reduces the research cycle for discovering new chemicals and materials from years to mere months. This platform combines advanced AI decision-making with robotic automation, facilitating the efficient creation of innovative materials that enhance public health and promote sustainability. In addition to its core offerings, Kebotix provides partners with access to its digital research and development solutions, enabling the advancement of green chemistry and the reduction of hazardous substances in production processes.

Verve Motion specializes in the development of lightweight wearable exo-suits aimed at enhancing the safety and comfort of workers engaged in physically demanding tasks. By integrating robotics, apparel design, and movement science, the company creates innovative textile-based solutions that adapt to the movements of the wearer. These exo-suits provide support by delivering force at critical moments while remaining nonrestrictive, thereby promoting a safer work environment. Additionally, Verve Motion's designs contribute to a more restful experience for workers during their off-hours.

Xibus Systems, Inc. is a biotechnology company based in Somerville, Massachusetts, specializing in the development of microbiological analytics and testing tools. The company focuses on creating solutions that detect pathogens, allergens, and spoilage organisms in consumable products. By integrating materials science, biotechnology, and optics, Xibus Systems aims to provide quantitative and array-based testing capabilities that are both efficient and cost-effective. Their innovative technology is designed for high throughput and rapid results, while also featuring a roadmap for compact and handheld hardware options. This unique combination of proprietary materials and biological agents positions Xibus Systems to effectively address the growing demands for food safety and quality assurance in the market.

C2Sense is currently working to bring two products to market: Halo Diagnostics, a digitally connected immunoassay reader with a user-friendly hardware and software, provide near-PCR sensitivity to address the gap in the patient-to-provider workflow. The Halo hardware is supported by a cloud-based, HIPAA compliant software solution that provides real-time test results to patients using an app (iOS/Android) or a web portal and, simultaneously, can be shared with a Telehealth physician to expedite time sensitive therapeutic prescriptions. To rapidly scale this technology, C2Sense partners with with immunoassay test manufacturers that own large portfolios of antigen tests that, pre-pandemic, had been exclusively providing tests to hospitals and urgent care facilities. By pairing these tests with a digitally enabled, highly sensitive test readers, remote physicians have access to store and review the same test results their patients are seeing in real time. In conjunction with Halo, C2Sense has designed different sensing solutions to provide product quality information and counterfeit detection from the point of manufacturing out to the customer. Discretely printed onto or included in a product, the tags are safe, versatile molecular additives that instantaneously report valuable information about the status of a good. They identify counterfeits and, where required, they are designed to react to problems encountered in the distribution chain (temperature change, oxygen sensing, and more). The tags are compatible with products as small as a pill, or can coat entire packaging surfaces, enabled by the tags’ compatibility with a myriad of printing and coating techniques.

Lucy Therapeutics is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative treatments for neurological diseases that originate in the mitochondria. Founded in 2017, the company employs a unique drug discovery approach that targets early disease pathogenesis, aiming to modify disease progression rather than merely alleviate symptoms. Their primary focus is on Rett Syndrome, a severe pediatric condition for which no effective drug treatments currently exist. In addition to Rett Syndrome, Lucy Therapeutics plans to expand its research to address other neurologically focused diseases, including Parkinson's and Alzheimer's diseases. The company also develops proprietary small molecule therapies and diagnostic biomarkers for the central nervous system, utilizing genetic technologies to provide insights into personalized medicine and enhance patient outcomes.

Kebotix, Inc. is a company focused on revolutionizing the materials discovery and production process through the integration of artificial intelligence, machine learning, and robotics. Founded in 2017 and headquartered in Cambridge, Massachusetts, Kebotix has developed a platform that significantly reduces the research cycle for discovering new chemicals and materials from years to mere months. This platform combines advanced AI decision-making with robotic automation, facilitating the efficient creation of innovative materials that enhance public health and promote sustainability. In addition to its core offerings, Kebotix provides partners with access to its digital research and development solutions, enabling the advancement of green chemistry and the reduction of hazardous substances in production processes.